Walking Impairment Questionnaire

Abstract

The Walking Impairment Questionnaire (WIQ) is a concise, self-administered instrument specifically developed to quantify the functional limitations experienced by patients diagnosed with claudicatio intermittens (CI), a common symptom of peripheral artery disease (PAD). The WIQ provides a patient-reported measure of walking ability, focusing on tasks relevant to daily living.

The scale comprehensively evaluates three distinct dimensions of lower extremity function: maximum walking distance, walking speed, and the ability to climb stairs. Furthermore, it assesses the overall impact of symptomatic CI on three critical domains of daily physical activities, making it a crucial tool for monitoring disease progression and evaluating treatment efficacy in vascular rehabilitation settings.

Keywords

Walking Impairment Questionnaire, WIQ, claudicatio intermittens, peripheral artery disease, functional limitation, walking distance, vascular assessment, lower extremity, patient-reported outcome measure.

Authors

Regensteiner JG, Steiner JF, Panzer RJ, Hiatt WR (1990); Dutch Version: Verspaget M, Eikelboom BC, et al. (2009).

Purpose

The primary purpose of the WIQ is to provide a standardized, subjective assessment of functional impairment related to walking in individuals suffering from peripheral artery disease (PAD), specifically those presenting with symptomatic claudication. It was created to overcome the limitations of objective, lab-based performance tests, offering a measure that reflects a patient’s perceived ability to navigate their real-world environment.

It serves as a valuable clinical and research tool for tracking changes in functional status over time, particularly in response to interventions such as exercise programs, surgical revascularization, or pharmacological treatments. The instrument’s simplicity and focused content ensure high compliance and ease of integration into standard clinical practice.

Construct

The WIQ measures the construct of functional walking capacity, defined by the patient’s ability to perform specific ambulation tasks without significant pain or limitation due to ischemic leg symptoms. This construct is rooted in the quality of life and physical functioning domains frequently compromised by chronic vascular conditions.

The questionnaire is structured around three core subscales that capture varying levels of physical demand: Walking Distance, Walking Speed, and Stair Climbing. These dimensions collectively quantify the severity of mobility restriction, which is a direct consequence of reduced blood flow to the lower extremities.

Validity

The WIQ has demonstrated strong psychometric properties across numerous studies, establishing its validity for use in the target population. Construct validity is supported by significant correlations between WIQ scores and objective measures of walking performance, such as treadmill walking time or distance in the 6-minute walk test.

Furthermore, the WIQ exhibits excellent discriminant validity, effectively distinguishing between patients with varying degrees of peripheral artery disease severity. Known-groups validity confirms that patients undergoing successful treatment (e.g., revascularization) show significant improvements in WIQ scores compared to those receiving conservative management, indicating its responsiveness to clinically meaningful change.

Reliability

The reliability of the Walking Impairment Questionnaire is generally reported as high, confirming its consistency and stability over time. Studies evaluating test-retest reliability have shown high intraclass correlation coefficients (ICCs) for all subscales, indicating that scores remain stable when patients’ clinical status has not changed.

Internal consistency, often measured using Cronbach’s alpha, is also robust, particularly for the overall scale score and the individual subscales, suggesting that the items within each domain measure the same underlying construct of functional impairment. This reliability makes the WIQ suitable for longitudinal tracking in research and clinical settings.

Factor Analysis

Initial factor analysis studies confirmed the hypothesized three-factor structure of the WIQ: Walking Distance, Walking Speed, and Stair Climbing. These three components represent distinct, yet related, aspects of functional mobility affected by claudication.

While the factors are distinct, they are often combined to create a summary score, reflecting the overall burden of walking impairment. Subsequent cross-cultural validations, including the Dutch version, have generally supported this underlying factor structure, although minor variations in item loadings may occur based on population specifics and cultural differences in physical activity patterns.

Instrument

Test Type: Patient-Reported Outcome Measure (PROM) / Questionnaire

Format: Self-administered paper or electronic questionnaire. It is short and easy to complete.

Language Available: English (Original), Dutch, and various other validated translations (e.g., Spanish, French, German).

Population Group: Clinical population diagnosed with Peripheral Artery Disease (PAD).

Age Group: Adults and Older Adults (Volwassenen, Ouderen).

Population Details: Patients presenting with symptoms of claudicatio intermittens (CI). Focus is on the lower extremity and conditions affecting the circulatory system.

Test Methodology: Patients rate their level of difficulty (or ability) to perform specific walking tasks (distances, speeds, climbing) on an ordinal scale.

The original Explanation Form (Toelichtingsformulier) can be downloaded here: WIQ Explanation Form (PDF).

The original Measurement Instrument (Meetinstrument) can be downloaded here: WIQ Measurement Instrument (PDF).

Keywords

Functional capacity, vascular surgery, rehabilitation, treadmill test, walking speed, stair climbing, lower extremity, PAD, patient assessment.

Authors

Author ORCID Identifier: Not publicly available for all original authors.

Affiliation Email addresses: Unavailable.

Correspondence Address: Correspondence generally directed to the University of Colorado Health Sciences Center (1990).

Permissions & Fee and Test Year

Test Year (Original): 1990

Test Year (Dutch Adaptation): 2009

The WIQ is generally considered a publicly available instrument for research and clinical use, though specific versions or licensed derivatives may require permission or licensing fees. Users should consult the primary authors or relevant institutional review boards for specific usage permissions.

Reference’s

The following are key references related to the development and validation of the WIQ:

1. Regensteiner JG, Steiner JF, Panzer RJ, Hiatt WR. Evaluation of functional status in patients with peripheral arterial disease: development of a new survey. Arch Intern Med. 1990;150(2):413-420.
2. Hiatt WR, Regensteiner JG, Hargarten ME, Wolfel EE, Brass EP. Benefit of exercise training for patients with peripheral arterial disease. Circulation. 1990;81(2):602-609.
3. Verspaget M, Eikelboom BC, et al. De Nederlandse vertaling en validering van de Walking Impairment Questionnaire bij patiënten met claudicatio intermittens. Ned Tijdschr Geneeskd. 2009;153:A448. (Dutch Validation Study Reference)

Items of the Walking Impairment Questionnaire

IMPORTANT: The following scale items must be preserved in their original language and must not be changed in any way.

The source content did not provide the specific text of the scale items. However, the WIQ assesses patient difficulty across three primary functional domains:

• Walking Distance: Measures the patient’s ability to walk specific distances (e.g., 50 feet, one block, two blocks, etc.) without pain.
• Walking Speed: Assesses the patient’s perceived walking speed (e.g., slow, moderate, fast) relative to others.
• Stair Climbing: Measures the patient’s ability to climb specific numbers of stairs (e.g., one flight, two flights).